Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Alzheimer's disease and diabetes: Hope for inhibitors against amyloid plaques

07.08.2018

Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes are not yet available. Scientists at the Technical University of Munich (TUM) have now come a little bit closer to a solution: They have described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation.

Amyloid plaques, which are protein deposits, play a crucial role in the development of Alzheimer's disease and type 2 diabetes. Several teams of scientists around the world are working on finding ways to prevent amyloid plaque formation in the human brain.


A new class of designed macrocyclic peptides has been developed which are highly potent inhibitors of amyloid plaque formation.

Picture: Kapurniotu/ TUM

The research team of Aphrodite Kapurniotu, Professor for Peptide Biochemistry (TUM) has been working on an idea for some time now in collaboration with the teams of Professor Martin Zacharias (TUM), Professor Gerhard Rammes (TUM Rechts der Isar Hospital) and Professor Jürgen Bernhagen (Institute for Stroke and Dementia Research (ISD) at Ludwig Maximilian University (LMU)). The researchers present now macrocyclic peptides (MCIPs) as potent inhibitors of amyloid formation; they reported their results in the journal "Angewandte Chemie”. The work has been supported by Deutsche Forschungsgemeinschaft (DFG) collaborative research center SFB 1035.

New class of amyloid inhibitors

In its new study, the team presents macrocyclic peptides, developed as a new class of amyloid inhibitors. "We have discovered an MCIP that is stable in human blood plasma and can also overcome the human blood-brain barrier in an in vitro cell culture model," explains Professor Kapurniotu.

She adds: "So far we were 'only' able to demonstrate these properties in the test tube - thus further research is necessary. But these are two highly desirable properties for inhibitors of Alzheimer's amyloid."

TUM has already applied for a patent for the newly developed macrocyclic peptides. "They could be a good alternative to the currently pursued antibody-based approaches as therapeutics against Alzheimer's amyloid plaque formation because they are easy to produce, have promising properties and, due to their peptidic nature, they will be significantly cheaper than antibodies," says Professor Kapurniotu.

"Therefore, further investigations are now planned to verify whether the MCIPs are also effective in in vivo models. Furthermore, the MCIPs could also be suitable as templates for the development of small molecule peptidomimetics (molecules mimicking peptide chains), which might also find application as anti-amyloid drugs in Alzheimer's and type 2 diabetes.

Further information:
The research work was funded by the German Research Foundation (DFG) within the SFB 1035.

Wissenschaftliche Ansprechpartner:

Prof. Dr. Aphrodite Kapurniotu
Technical University of Munich
Division of Peptide Biochemistry
Phone: 0049/8161/713542
Mail: akapurniotu@wzw.tum.de
http://pbch.wzw.tum.de/index.php?id=9

Originalpublikation:

Publication:
Anna Spanopoulou, Luzia Heidrich, Hong‐Ru Chen, Christina Frost, Dean Hrle, Eleni Malideli, Kathleen Hille, Alexandros Grammatikopoulos, Jürgen Bernhagen, Martin Zacharias, Gerhard Rammes and Aphrodite Kapurniotu: Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements, Angew Chem Int Ed Engl. 06/2018.
DOI: 10.1002/anie.201802979.

Weitere Informationen:

https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/34885/

Dr. Ulrich Marsch | Technische Universität München

More articles from Life Sciences:

nachricht mRNA methylation: A novel mechanistic link between stress regulation and psychiatric disorders
07.08.2018 | Max-Planck-Institut für Psychiatrie

nachricht Gene recombination deactivates retroviruses during invasion of host genomes
07.08.2018 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Touring IPP’s fusion devices per virtual-reality viewer

ASDEX Upgrade and Wendelstein 7-X – as if you were there / 360° view of fusion research

You seem to be standing in the plasma vessel looking around: Where otherwise plasmas with temperatures of several million degrees are being investigated, with...

Im Focus: Concepts for new switchable plasmonic nanodivices

A magneto-plasmonic nanoscale router and a high-contrast magneto-plasmonic disk modulator controlled by external magnetic fields

Plasmonic waveguides open the possibility to develop dramatically miniaturized optical devices and provide a promising route towards the next-generation of...

Im Focus: 26AlF – the first detection of a radioactive molecule in space

The first unambiguous observation of a radioactive molecule, 26AlF, was made in the ancient nova-like object CK Vul (or Nova Vul 1670), which - most likely - is a stellar-merger remnant. The eruption of the object was observed between 1670-1672 in Europe. The interest in this object has been recently rejuvenated by the discovery of molecular gas of a very peculiar isotopic composition in the remnant.
The finding was announced by an international research team led by Tomasz Kamiński (CfA), including Karl Menten (MPIfR Bonn).

The variable star CK Vulpeculae (CK Vul) is known as the location of a stellar outbreak, a nova, which was observed by European astronomers in the 17th century...

Im Focus: Scientists create 'impossible' materials in simple way

Scientists from NUST MISIS and colleagues from the University of Bayreuth, the University of Münster (Germany), the University of Chicago (U.S.), and Linköping University (Sweden) have created nitrides, a material previously considered impossible to obtain. More amazing, they have shown that the material can be obtained using a very simple method of direct synthesis. Articles about the revolutionary research results have been published in Nature Communications and Angewandte Chemie International Edition.

Nitrides are actively used in superhard coatings and electronics. Usually, the nitrogen content in these materials is low, and it is therefore difficult to get...

Im Focus: World-first quantum computer simulation of chemical bonds using trapped ions

An international group of researchers has achieved the world’s first multi-qubit demonstration of a quantum chemistry calculation performed on a system of trapped ions, one of the leading hardware platforms in the race to develop a universal quantum computer.

The research, led by Cornelius Hempel and Thomas Monz, explores a promising pathway for developing effective ways to model chemical bonds and reactions using...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

 
Latest News

Alzheimer's disease and diabetes: Hope for inhibitors against amyloid plaques

07.08.2018 | Life Sciences

Touring IPP’s fusion devices per virtual-reality viewer

07.08.2018 | Power and Electrical Engineering

Planet at risk of heading towards irreversible “Hothouse Earth” state

07.08.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>